Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Friday, March 2, 2012 - 9:49am
tags:
SciClone, head and neck cancer, SCV-07, oral mucositis
Watson launches generic version of Abbott's Prometrium
Yahoo/Fly on the Wall
Friday, March 2, 2012 - 9:48am
tags:
generics, Abbott Laboratories, Prometrium
Judge refuses to halt Amgen-Micromet deal
Yahoo/AP
Thursday, March 1, 2012 - 6:03pm
tags:
Amgen, Micromet, M&A
Durect's partner Pfizer to end pain drug deal
Reuters
Thursday, March 1, 2012 - 6:02pm
tags:
Pfizer, Durect Corporation, Eladur
Pharmacyclics Gains Ahead of Investor Call
Bloomberg
Thursday, March 1, 2012 - 5:59pm
tags:
Pharmacyclics, JNJ
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thursday, March 1, 2012 - 12:45pm
tags:
FDA, Vertex, M&A, Kalydeco, cystic fibrosis
Spectrum Pharma 4Q profit grows, but shares fall
Yahoo/AP
Thursday, March 1, 2012 - 12:44pm
tags:
Spectrum Pharmaceuticals, earnings
Endo Pharmaceuticals to Change Name to Endo Health Solutions
Bloomberg
Thursday, March 1, 2012 - 12:43pm
tags:
Endo Health Solutions, Endo
Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Thursday, March 1, 2012 - 12:42pm
tags:
Allos, earnings
What BioSante's Balance Sheet Says About Future R&D
Seeking Alpha
Thursday, March 1, 2012 - 12:42pm
tags:
BioSante, R&D
Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze
Seeking Alpha
Thursday, March 1, 2012 - 12:35pm
tags:
Avanir, Nuedexta, PBA
Mylan begins selling lower-cost generic version of Forest Lab's antidepressant Lexapro
Yahoo/AP
Thursday, March 1, 2012 - 12:34pm
tags:
Mylan, Lexapro, generics, Forest Labs, antidepressants
US patent office rejects Amarin's patent application
Reuters
Thursday, March 1, 2012 - 12:34pm
tags:
Amarin, patents, AMR101
Parkinson’s Drug Helps Speed Recovery After Brain Trauma, Researchers Say
Bloomberg
Thursday, March 1, 2012 - 12:33pm
tags:
Parkinson's Disease, brain injury, brain trauma, amantadine
Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Yahoo/AP
Thursday, March 1, 2012 - 12:30pm
tags:
Elan, Pharma CEOs, Kelly Martin, Alzheimer's disease
Abbott to build nutritional plant in Ohio
Reuters
Thursday, March 1, 2012 - 12:26pm
tags:
Abbott Laboratories, Ohio, adult nutrition
AstraZeneca, Nycomed Antitrust Probe Ended by EU Regulators
Bloomberg
Thursday, March 1, 2012 - 12:24pm
tags:
AstraZeneca, Nycomed, Europe, antitrust, Takeda
Pfizer and Bristol-Myers’ Blood Thinner Delayed by FDA
Bloomberg
Thursday, March 1, 2012 - 10:48am
tags:
Pfizer, bloodthinners, FDA, Eliquis, Bristol-Myers Squibb
This Government Agency Can Make Drugmakers Billions
Motley Fool
Thursday, March 1, 2012 - 10:41am
tags:
CDC
Drugmaker Code Defines Gifts to Doctors as Industry Faces Marketing Probes
Bloomberg
Thursday, March 1, 2012 - 10:40am
tags:
physicians, physician gifts

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.